biogen inc (BIIB*:Mexico)
Transactions by BIOGEN INC (BIIB*) in the last 6 months
Biogen Inc. (NasdaqGS:BIIB) entered into a definitive agreement to acquire Research Triangle Park (RTP) manufacturing campus from Eisai Inc. on July 15, 2015. Under the terms of the agreement, Biogen will continue to manufacture oral solid-dose products for Eisai. In addition, Eisai has entered into a new manufacturing agreement whereby Biogen will manufacture Eisai's parenteral products. The property ownership transfer comprises all buildings on the campus. The parenteral ...
Applied Genetic Technologies Corporation (NasdaqGM:AGTC) announced that it has entered into an agreement for a private placement of 1,453,981 common shares with new investor Biogen Inc. at $20.63 per share for gross proceeds of $30,000,000 on July 2, 2015. The transaction is expected to close in the third quarter of 2015.
Biogen Inc. (NasdaqGS:BIIB) announces a share repurchase program. Under the program, the company will repurchase up to $5,000 million worth of its common stock. The repurchased shares will be retired. The share repurchase program does not have an expiration date. The company currently expects that purchases will be executed within a period of up to five years.
The Board of Directors of Biogen Inc. has authorized a buyback plan on May 7, 2015.
On May 7, 2015, the ...
|Abbott Laboratories||$40.65 USD||-0.74|
|Astellas Pharma Inc||¥1,585 JPY||+8.00|
|Celgene Corp||$111.24 USD||-5.38|
|Shire PLC||4,524 GBp||-80.00|
|Thermo Fisher Scientific Inc||$123.64 USD||-2.91|
|View Industry Companies|